Have yields peaked?
The local highlight this week will be Thursday’s September employment report, with a further solid 20k gain in employment expected, which should keep the unemployment rate steady at 3.7%.
Get expert investment analysis on the Australian stockmarket, economy and property from Rask Media’s chosen fund managers, selected analysts and writers. Stay up to date with your preferred experts by creating a free Rask account.
The local highlight this week will be Thursday’s September employment report, with a further solid 20k gain in employment expected, which should keep the unemployment rate steady at 3.7%.
Welcome to the latest edition of 2 Sense on the
Many of us have been taught from an early age that we shouldn’t talk about money, but I think that the taboo does much more harm than good.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.68% to 7088.40.
As more Australians continue to use ETFs, it’s important for investors to understand these essential tips, from the advantages of broad diversification and cost-efficiency, to comparing ETFs and understanding the role of market makers and authorised participants.
In a higher rate environment with equities offering an underwhelming risk premium, many are questioning whether equities still offer much capital growth upside.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.01% to 7040.60.
Sonic Healthcare Ltd (ASX: SHL) has traditionally viewed as an ASX share that provides a mixture of dividends and defensive growth for investors. However, SHL shares have been sold off 17% over the last 6 months.
Welcome to a Tuesday edition of 2 Sense on the
The local highlight this week will be Thursday’s September employment report, with a further solid 20k gain in employment expected, which should keep the unemployment rate steady at 3.7%.
Welcome to the latest edition of 2 Sense on the
Many of us have been taught from an early age that we shouldn’t talk about money, but I think that the taboo does much more harm than good.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.68% to 7088.40.
As more Australians continue to use ETFs, it’s important for investors to understand these essential tips, from the advantages of broad diversification and cost-efficiency, to comparing ETFs and understanding the role of market makers and authorised participants.
In a higher rate environment with equities offering an underwhelming risk premium, many are questioning whether equities still offer much capital growth upside.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.01% to 7040.60.
Sonic Healthcare Ltd (ASX: SHL) has traditionally viewed as an ASX share that provides a mixture of dividends and defensive growth for investors. However, SHL shares have been sold off 17% over the last 6 months.
Welcome to a Tuesday edition of 2 Sense on the
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) and Target Market Determination before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024